Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Sustainable seafood startup creating lab-engineered shrimp for mass consumption

Add as a preferred source on Google

Silicon Valley is a not only a hotbed for information technology, it’s also a center for other technology disciplines, including the growing niche of food technology. One of the most ambitious of these endeavors is being undertaken by sustainable seafood startup New Wave, which is working on a lab-engineered shrimp substitute and shark fin replacement intended to grace the plates of foodies around the world.

New Wave is the brain child of Jennifer Kaehms, Michelle Wolf, and Dominique Barnes. The trio is focusing on sustainable seafood, using technology to create alternative forms of popular seafood delicacies. These fabricated food items allow people to consume their favorite seafood without impacting the animal population or its ecology.

Recommended Videos

The team chose to work on a shark fin substitute because of the impact that shark fin harvesting –the practice of removing a shark fin and throwing the finless body back into the sea– has had on the shark population. With up to 73 million shark fins harvested annually, shark populations have suffered serious declines in those areas where harvesting is active. The team molds its substitute shark fins using collagen produced from genetically modified yeast. They hope to provide an ecologically-friendly alternative source of shark fins for consumers who want a guilt-free food source or are seeking to avoid pollution in their food.

Besides shark fins, the company also is actively developing a shrimp substitute because that edible crustacean is such a high-profile seafood item. “Shrimp is the highest volume consumed seafood in the US,” says co-founder Kaehms, “so it just made sense for us to start with something that can make the biggest splash.”

The shrimp substitute is being developed to match the taste, texture and nutritional composition of real shrimp by turning towards the algae that shrimp consume in the wild as an input. The team is working on different ways of extracting protein from the algae and mixing it in a way that makes its appealing to eat. While the team allegedly has nailed the flavor aspect, they are continuing to tweak the texture of shrimp, which is difficult to replicate. They hope to demonstrate their first shrimp product in February of next year as part of their participation in IndieBio, a startup incubator that helps fund innovations in biotechnology.

Kelly Hodgkins
Kelly's been writing online for ten years, working at Gizmodo, TUAW, and BGR among others. Living near the White Mountains of…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more